Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

UNICHEM LABORATORIES LTD.

NSE : UNICHEMLABBSE : 506690ISIN CODE : INE351A01035Industry : Pharmaceuticals & DrugsHouse : Private

BSE432.1054.05 (+14.3 %)

PREV CLOSE ( ) 378.05

OPEN PRICE ( ) 380.00

BID PRICE (QTY) 433.00 (454)

OFFER PRICE (QTY) 434.25 (5)

VOLUME 145582

TODAY'S LOW / HIGH ( )378.85 447.00

52 WK LOW / HIGH ( )280 666

NSE435.8556.2 (+14.8 %)

PREV CLOSE( ) 379.65

OPEN PRICE ( ) 379.00

BID PRICE (QTY) 435.35 (1)

OFFER PRICE (QTY) 435.80 (54)

VOLUME 3517183

TODAY'S LOW / HIGH( ) 376.60 447.45

52 WK LOW / HIGH ( )278.2 666.6

Select year

(Rs.in Million)

Particulars

Mar 2025

Mar 2024

Mar 2023

Mar 2022

Mar 2021

Profit Before Tax

1545.90

-849.60

-1763.63

219.69

514.79

Adjustment

1487.00

1973.20

1328.44

804.63

656.48

Changes In working Capital

-2938.90

-919.90

-293.61

-3544.29

-697.82

Cash Flow after changes in Working Capital

94.00

203.70

-728.80

-2519.97

473.46

Cash Flow from Operating Activities

-70.20

140.00

-850.91

-2596.12

329.82

Cash Flow from Investing Activities

-2412.30

504.00

2028.13

1023.98

-735.58

Cash Flow from Financing Activities

1837.60

-1063.10

-813.00

1912.28

-1210.75

Net Cash Inflow / Outflow

-644.90

-419.10

364.23

340.14

-1616.50

Opening Cash & Cash Equivalents

1547.50

1837.50

1091.96

774.61

2315.18

Cash & Cash Equivalent on Amalgamation / Take over / Merger

-6.80

129.10

381.33

-22.78

75.92

Cash & Cash Equivalent of Subsidiaries under liquidations

Translation adjustment on reserves / op cash balalces frgn subsidiaries

Effect of Foreign Exchange Fluctuations

Closing Cash & Cash Equivalent

895.80

1547.50

1837.52

1091.96

774.61